A flow cytometry (FCM) study of 35 Kaposi's sarcomas (KS) from HIV+ patients (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


A flow cytometry (FCM) study of 35 Kaposi's sarcomas (KS) from HIV+ patients (Meeting abstract).

J Pathol; 168(Suppl):113A 1992. Unique Identifier : AIDSLINE ICDB/93689089
El-Jabbour J; Wilson G; Henry K; Hawkins D; McLean K; Sannino P; Barrett M; Dept. of Histopathology Charing Cross and Westminster Medical; Sch., London, UK


Abstract: KS is a common disease in HIV+ patients and is a marker of their progression to AIDS. However, it is not yet clear whether KS is a neoplastic or a hyperplastic process. Recent FCM studies on sporadic KS (from HIV- individuals) have shown a low rate of DNA-aneuploidy. We document here the results of a FCM analysis of 35 KS lesions (20 cutaneous and 15 noncutaneous) excised from 30 HIV+ individuals and discuss the implications as to the nature of KS. Three 50-um thick formalin-fixed paraffin sections were cut and processed by a modification of Hedley's method. The presence of KS in the analyzed sections was verified, and at least 10,000 single nuclei events were collected for each specimen. Median coefficient variation was 5.19 (range 3.5-11.3). Two cases (an axillary lymph node and a skin) out of 35 KS lesions were aneuploid with a DNA index of 1.14 and 1.22, respectively. The proliferative fraction (%S+G2/M) was high in these two cases (29.7% and 31.8%), compared with a median of 15.87% in the 33 diploid cases (range 7.6-30%). Diploid KS lesions of either a capillary or a cavernous hemangiomatous pattern displayed a higher %S+G2/M than those KS with a mixed vascular pattern (chi2, DF1 [p less than 0.05 but greater than 0.02]); this finding is being investigated further. No correlation with growth phase, cellular pattern, mitoses, nuclear atypia, lymphocytic response or size is found. A low aneuploidy rate (5.7%) is shown in HIV+ KS similar to that reported in KS from HIV individuals, thus suggesting that at least a small proportion of KS may be genuinely neoplastic. KS seems to have a high %S+G2/M; comparison of this finding with FCM of granulation tissue and malignant vascular tumor is providing interesting results which should give further insight into the nature of KS.
Keywords: Aneuploidy DNA, Neoplasm/GENETICS *Flow Cytometry Human HIV Seropositivity/*PATHOLOGY Lymph Nodes/PATHOLOGY Sarcoma, Kaposi's/*PATHOLOGY Skin/PATHOLOGY Skin Neoplasms/*PATHOLOGY ABSTRACTKWDaneuploidydna,neoplasm/geneticsKWDflowcytometryhumanhivseropositivity/KWDpathologylymphnodes/pathologysarcoma,kaposi's/KWDpathologyskin/pathologyskinneoplasms/KWDpathologyabstract
930330
M9331094

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .